LLMs for Medical Device Regulatory Science — Scaling Compliance with AI
CONCEPTA Nature npj Digital Medicine publication explores the use of large language models to scale medical device regulatory science — applying AI to the regulatory process itself rather than only to clinical applications. The research addresses a practical bottleneck: regulatory review of AI medical devices requires substantial human expertise that is in short supply at agencies like the FDA and EMA. LLMs applied to regulatory science could assist with literature review for predicate device identification, draft submission document generation, regulatory pathway analysis, and post-market surveillance data synthesis. These applications could accelerate review timelines and reduce the burden on regulatory staff without compromising the quality of safety and efficacy assessments. The approach raises governance questions: if LLMs assist in regulatory review, what oversight mechanisms ensure AI-assisted decisions meet the same quality standards as human review? The publication contributes to an emerging conversation about AI as a tool for regulatory modernization, complementing its role as the subject of regulation. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.